Format

Send to

Choose Destination
Diabetologia. 2019 Jun;62(6):1094-1095. doi: 10.1007/s00125-019-4853-x. Epub 2019 Mar 25.

Underpowered or negative? A crucial distinction.

Author information

1
Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Integrative Physiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
2
Medical Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
3
Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital and Central Denmark Region, Hedeager 3, DK-8200, Aarhus N, Denmark. Niels.Jessen@biomed.au.dk.
4
Department of Biomedicine, Aarhus University, Aarhus, Denmark. Niels.Jessen@biomed.au.dk.

KEYWORDS:

Clinical trial; Human; Hyperinsulinaemic–euglycaemic clamp; Insulin sensitivity; NAD+ metabolism; Nicotinamide riboside

PMID:
30911774
DOI:
10.1007/s00125-019-4853-x

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center